Language selection

Search

Details for: METOJECT SUBCUTANEOUS

Company: MEDEXUS INC

DIN DIN name Active Ingredient(s) Strength Dosage Form Route of Administration
02454831METOJECT SUBCUTANEOUSMETHOTREXATE (METHOTREXATE SODIUM)10 MG / 0.2 MLSOLUTIONSUBCUTANEOUS
02454750METOJECT SUBCUTANEOUSMETHOTREXATE (METHOTREXATE SODIUM)12.5 MG / 0.25 MLSOLUTIONSUBCUTANEOUS
02454858METOJECT SUBCUTANEOUSMETHOTREXATE (METHOTREXATE SODIUM)15 MG / 0.3 MLSOLUTIONSUBCUTANEOUS
02454769METOJECT SUBCUTANEOUSMETHOTREXATE (METHOTREXATE SODIUM)17.5 MG / 0.35 MLSOLUTIONSUBCUTANEOUS
02454866METOJECT SUBCUTANEOUSMETHOTREXATE (METHOTREXATE SODIUM)20 MG / 0.4 MLSOLUTIONSUBCUTANEOUS
02454777METOJECT SUBCUTANEOUSMETHOTREXATE (METHOTREXATE SODIUM)22.5 MG / 0.45 MLSOLUTIONSUBCUTANEOUS
02454874METOJECT SUBCUTANEOUSMETHOTREXATE (METHOTREXATE SODIUM)25 MG / 0.5 MLSOLUTIONSUBCUTANEOUS
Search Reported Side Effects Report a Side Effect

Summary Reports

Regulatory Decision Summary
Summary Safety Review - Levetiracetam and Methotrexate - Assessing the Potential Risk of Drug-Drug Interaction

Consumer Information

The Consumer Information is not yet available in the Drug and Health Product Register. Try searching on the active ingredient(s) to find other similar products.

Date modified: